Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection (2024)
- Authors:
- Autor USP: KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1126/scitranslmed.ade5795
- Subjects: VETORES; FEBRE AMARELA; BRASIL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2024
- Source:
- Título: Science translational medicine
- ISSN: 1946-6234
- Volume/Número/Paginação/Ano: v. 15, n. 689, article ID eade5795, 10p, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
RICCIARDI, Michael J et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, v. 15, n. 689, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53922. Acesso em: 03 dez. 2025. -
APA
Ricciardi, M. J., Rust, L. N., Pedreno-lopez, N., Yusova, S., Biswas, S., Webb, G. M., et al. (2024). Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, 15( 689). doi:10.1126/scitranslmed.ade5795 -
NLM
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2025 dez. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922 -
Vancouver
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2025 dez. 03 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922 - Lower numbers of natural killer T cells in HIV-1 and mycobacterium leprae co-infected patients
- No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
- HLA-C downregulation by HIV-1 adapts to host HLA genotype
- Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
- Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
- Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial
- Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
- Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
- Syndemics among individuals enrolled in the PrEP Brasil Study
Informações sobre o DOI: 10.1126/scitranslmed.ade5795 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
